	2012 Mar 31	2013 Mar 31	C 2014 Mar 31	2015 Mar 31	R 2016 Mar 31	C 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Total Revenue	3,148	3,769	4,384	5,178	6,215	7,256	8,243	9,617	11,247	10,560	14,663	16,613	19,059	21,794	25,229
Cost of Operating Revenue	1,686	1,998	2,318	2,793	3,319	3,912	4,391	5,056	6,118	6,257	8,174	9,189	10,492	12,067	13,952
Gross Profit	1,461	1,771	2,066	2,386	2,896	3,343	3,852	4,562	5,129	4,303	6,489	7,423	8,567	9,727	11,277
Gross Margin	46.4	47.0	47.1	46.1	46.6	46.1	46.7	47.4	45.6	40.8	44.3	44.7	45.0	44.6	44.7
Total Operating Expenses	2,755	3,299	3,876	4,652	5,784	6,836	7,796	8,940	10,270	9,981	13,072	15,160	17,350	19,516	22,335
Operating Profit	393	470	508	527	430	420	447	678	976	579	1,590	1,452	1,709	2,278	2,893
Operating Margin	12.5	12.5	11.6	10.2	6.9	5.8	5.4	7.0	8.7	5.5	10.8	8.7	9.0	10.5	11.5
Financing Income/(Expense) - Net	-66	-80	-100	-102	-149	-223	-268	-311	-520	-427	-337	-320	-398	-352	-450
Profit before Taxes	326	399	407	455	332	222	171	374	660	221	1,578	1,144	1,363	2,006	2,616
Income Taxes	115	105	102	130	97	91	112	173	225	85	477	256	446	534	658
Profit after Tax	219	304	317	340	236	221	117	236	455	150	1,056	819	899	1,446	1,942
PAT Margin	7.0	8.1	7.2	6.6	3.8	3.0	1.4	2.5	4.0	1.4	7.2	4.9	4.7	6.6	7.7
EPS - Basic - ex Extraordinary Items	16.83	22.08	22.77	24.43	16.99	15.88	8.44	16.97	32.69	10.74	73.42	56.97	62.50	100.56	135.04
EPS - Diluted - ex Extraordinary Items	16.30	21.88	22.77	24.43	16.99	15.88	8.44	16.97	32.69	10.74	73.42	56.97	62.50	100.56	134.94
EBIT	393	470	508	527	430	420	447	678	976	579	1,590	1,452	1,709	2,278	2,893
EBITDA	517	612	676	738	696	733	806	1,073	1,596	1,151	2,190	2,067	2,396	3,035	3,769
EBITDA Margin	16.4	16.2	15.4	14.3	11.2	10.1	9.8	11.2	14.2	10.9	14.9	12.4	12.6	13.9	14.9

Balance Sheet

Abridged

Understanding Balance Sheet

Apollo Hospitals Enterprise Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	R 2012 Mar 31	R 2013 Mar 31	2014 Mar 31	R 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	1,062	1,553	1,501	1,809	1,975	2,129	2,220	2,282	2,647	3,641	4,061	4,337	5,280	7,029	6,900
Long-Term Investments	53	80	91	21	31	29	24	34	41	42	159	233	147	882	1,261
Property Plant & Equipment - Net	2,054	2,565	2,987	3,538	4,206	4,556	5,091	5,416	7,261	6,546	7,289	8,034	9,385	10,587	12,030
Total Non-Current Assets	2,945	3,286	3,872	4,498	5,385	5,990	6,393	6,901	8,692	7,775	9,209	10,091	11,473	13,629	15,297
Total Assets	4,007	4,839	5,372	6,307	7,360	8,119	8,613	9,183	11,338	11,417	13,269	14,428	16,753	20,657	22,197
Total Current Liabilities	726	734	797	859	1,250	963	1,567	1,955	2,337	2,038	2,434	3,325	4,665	4,579	6,481
Long Term Debt	574	1,079	1,222	1,858	2,450	2,953	2,924	2,952	4,720	3,703	3,761	3,436	4,217	6,831	5,100
Total Non-Current Liabilities	761	1,341	1,580	2,096	2,701	3,718	3,662	3,759	5,531	4,577	4,932	4,572	4,768	7,426	5,741
Total Liabilities	1,488	2,075	2,377	2,956	3,951	4,682	5,229	5,714	7,869	6,614	7,366	7,897	9,433	12,005	12,222
Total Shareholders' Equity	2,507	2,747	2,977	3,284	3,331	3,313	3,252	3,333	3,339	4,603	5,623	6,197	6,935	8,212	9,480
Minority Interest	13	17	19	68	78	125	132	135	131	200	280	334	385	441	494
Total Equity	2,519	2,764	2,995	3,352	3,409	3,438	3,384	3,469	3,470	4,802	5,903	6,531	7,321	8,653	9,975
Total Liabilities & Equity	4,007	4,839	5,372	6,307	7,360	8,119	8,613	9,183	11,338	11,417	13,269	14,428	16,753	20,657	22,197

Cash Flow

Abridged

Understanding Cash Flow Statement

Apollo Hospitals Enterprise Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2012 Mar 31	2013 Mar 31	2014 Mar 31	2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	C 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	412	458	477	524	427	380	447	604	814	900	1,836	1,625	1,849	2,533	3,248
Working Capital - Increase/(Decrease)	-87	-90	-214	-161	11	-78	-207	-46	-70	-72	-359	-450	-193	-604	-574
Net CF from Operating Activities	325	368	263	364	438	301	240	558	744	828	1,477	1,175	1,657	1,929	2,674
Capital Expenditures - Net	387	660	596	865	990	-5	-1	-7	511	280	652	1,124	1,135	1,698	1,931
Net CF from Investing Activities	-495	-761	-366	-770	-922	-1,165	-426	-725	-304	-894	-883	-920	-1,577	-3,475	-2,244
Dividends Paid - Cash - Total	47	56	77	80	162	-	101	84	155	38	43	255	216	273	288
Stock - Issuance/(Retirement) - Net	416	163	7	42	3	606	8	-	-	1,152	-	5	3	47	3
Debt - LT & ST - Issuance/(Retirement) - Total	-145	369	126	548	682	206	302	235	-186	-986	-493	-128	225	1,887	90
Net Cash Flow from Financing Activities	225	476	57	510	523	811	209	148	-345	128	-536	-382	-8	1,619	-200
Free Cash Flow to Equity	-206	77	-207	46	129	511	543	799	47	-439	332	-78	746	2,118	834
Free Operating CF net dividend	-116	-348	-426	-584	-740	301	139	474	76	494	776	-209	304	-57	425
Free Operating CF	-69	-292	-349	-504	-578	301	240	558	231	532	820	46	520	216	712

Business Segment Analysis

FY End:

Mar 25

Apollo Hospitals Enterprise Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Revenue / Sales

Healthcare Services (51.3%)₹ 11,220.10 CrDigital Health & Pharmacy distribution (41.6%)₹ 9,093.00 CrRetail Health & Diagnostics (7.1%)₹ 1,553.50 CrOther (0.0%)₹ 4.80 Cr

Assets

Healthcare Services (61.7%)₹ 12,740.30 CrUnallocable (17.4%)₹ 3,598.40 CrDigital Health & Pharmacy distribution (14.3%)₹ 2,962.90 CrRetail Health & Diagnostics (6.4%)₹ 1,327.70 CrOther (0.1%)₹ 28.00 Cr

Regional Segment Analysis

Apollo Hospitals Enterprise Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Apollo Hospitals Enterprise Ltd.

Historical Segment Analysis

Track how Apollo Hospitals Enterprise Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Business

Regional

Business

	2010 Mar 31	2011 Mar 31	2012 Mar 31	2013 Mar 31	2014 Mar 31

Healthcare Services	313	253	503	399	520
Other	4	8	24	67	2
Retail Pharmacy	24	17	23	21	23

Frequently Asked Questions

What is the revenue of Apollo Hospitals Enterprise Ltd.?

The latest trailing twelve month revenue of Apollo Hospitals Enterprise Ltd. is ₹ 25,228.50 Cr, reflecting a 1-year growth of 15.76% and a 3-year CAGR of 14.94%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Apollo Hospitals Enterprise Ltd.?

The latest trailing twelve month net profit (PAT) of Apollo Hospitals Enterprise Ltd. is ₹ 1,941.70 Cr, with a 3-year earnings CAGR of 33.30%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Apollo Hospitals Enterprise Ltd.?

The trailing twelve month EBITDA of Apollo Hospitals Enterprise Ltd. is approximately ₹ 2,893.20 Cr (based on an operating margin of 11.47%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Apollo Hospitals Enterprise Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Apollo Hospitals Enterprise Ltd. is 134.94. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Apollo Hospitals Enterprise Ltd.?

The debt-to-equity ratio of Apollo Hospitals Enterprise Ltd. stands at 0.90. The interest coverage ratio is 6.44x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Apollo Hospitals Enterprise Ltd.?

The estimated book value per share of Apollo Hospitals Enterprise Ltd. is 675.28 (derived from a P/B ratio of 13.19 and market price of ₹ 8,906.50), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Apollo Hospitals Enterprise Ltd.?

The trailing twelve month operating cash flow of Apollo Hospitals Enterprise Ltd. is ₹ 2,674.20 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Apollo Hospitals Enterprise Ltd. report consolidated or standalone financials?

Apollo Hospitals Enterprise Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.